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Abstract 
Background. As a physiological condition closely linked with increased susceptibility to oxidative stress, preg-
nancy can be further compromised by cigarette smoking. Inadequate nutrition and reduced intake of antioxidants 
can also disrupt the prooxidant/antioxidant relationship and contribute to oxidative stress. Increased oxidative 
stress during pregnancy may be involved in several complications of pregnancy, such as preterm labor, fetal growth 
restriction, preeclampsia and miscarriage.
Objectives. The aim of this study was to investigate the influence of maternal smoking habits before pregnancy 
on the parameters of oxidative stress and the antioxidative defense system, lipid profile parameters and paraoxo-
nase-1 (PON1) activity during the third trimester of uncomplicated pregnancies.
Material and Methods. Healthy pregnant women (n = 86) were divided into non-smoking and smoking groups, 
and into groups taking vitamin supplements and not taking them. Oxidative damage was measured through the 
levels of thiobarbituric acid-reacting substances (TBARS) and plasma antioxidant status was evaluated by measur-
ing total antioxidant capacity (TAC). 
Results. TBARS concetration was significantly higher (p < 0.05) and PON1 activity was significantly lower (p <  0.05) 
in the smokers’ group. No significant differences were found in the investigated parameters in relation to vitamin 
supplement intake.
Conclusions. Habitual smoking before pregnancy is associated with increased oxidative stress. Vitamin supple-
mentation has no effect on the oxidative stress status of healthy pregnant women (Adv Clin Exp Med 2014, 23, 
4, 575–583).
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Pregnancy is a physiological condition close-
ly linked with increased susceptibility to oxidative 
stress [1]. Oxidative stress is an imbalance between 
the systemic manifestation of reactive oxygen spe-
cies (ROS) and the antioxidative system’s ability 
to readily detoxify reactive intermediates [2]. In-
creased oxidative stress during pregnancy could 
be involved in several complications of pregnancy, 
such as preterm labor, fetal growth restriction and 
preeclampsia [2]. 
* The authors appreciate the financial support provided for this study by the Ministry of Science and Technological 
Development, Republic of Serbia (project No. 175035).
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It is well known that tobacco smoke may in-
voke oxidative stress [3]. In pregnant women, the 
nicotine and carbon monoxide components of cig-
arette smoke may cause damage to both the moth-
er and the fetus, crossing the placental barrier [3]. 
A number of studies suggest a relationship between 
maternal smoking and not only intrauterine fetal 
growth retardation or low birth weight [4], but also 
with disturbances in postnatal growth and devel-
opment [5]. As pregnancy is a period of increased 
metabolic demands, insufficient supplies of essen-
tial vitamins and micronutrients can lead to a state 
of biological competition between the mother and 
fetus [6]. In such a situation, inadequate nutrition 
and a reduced intake of antioxidants may also dis-
rupt the prooxidant/antioxidant relationship and 
contribute to oxidative stress.
In addition, it is well known that lipid metab-
olism is altered during pregnancy by the effects of 
estrogen, progesterone, and human placental lac-
togen [7]. These alterations are characterized by 
normal concentrations of total cholesterol dur-
ing early pregnancy, and by hypertriglyceridemia 
and hypercholesterolemia in late pregnancy [7]. 
An increase in low-density lipoprotein cholesterol 
(LDL-C) and its oxidative modification are impor-
tant steps in the development of atherosclerosis. 
Higher LDL-C concentrations during late preg-
nancy followed by intensive oxidative stress could 
be initial reasons for an increased risk of develop-
ing cardiovascular disease in later life.
Paraoxonase-1 (PON1) is part of the enzyme 
antioxidant potential of the organism, and is re-
lated to high-density lipoprotein (HDL) particles. 
The defensive role of PON1 is the metabolism of 
oxidative LDL-C particles [8], and lower PON1 ac-
tivity is connected with cardiovascular disease.
The aim of this study was to investigate the in-
fluence of maternal smoking habits before preg-
nancy on the parameters of oxidative stress and the 
antioxidative defense, lipid profile parameters and 
PON1 activity during the third trimester of un-
complicated pregnancies. The influence of antiox-
idative vitamin supplementation during pregnan-
cy on oxidative stress status was also examined. 
Material and Methods 
For the study, 86 healthy pregnant Caucasians 
were recruited during their regular gynecological 
check-ups at the Narodni Front Gynecology and Ob-
stetrics Clinic in Belgrade. The median week of preg-
nancy was 34 (range 31–38), and none of the partici-
pants had any identifiable risk factors for the current 
pregnancy. A full medical history was taken, includ-
ing noting the presence of any systemic disorders 
before pregnancy, smoking status, alcohol intake, an-
tioxidant supplementation and family history of car-
diovascular disease and diabetes mellitus. The medi-
an age of the subjects was 26 years (range 20–35).
Non-smokers were defined as women who had 
never smoked either before or during pregnancy. 
Smokers were defined as those who reported that 
they had smoked habitually before pregnancy and 
gave up smoking during pregnancy. In the study 
population 42 women (48.8%) had been active 
smokers before pregnancy. 
All the participants were specifically advised to 
consume a variety of foods to get all the nutrients 
they needed. Sparing use of fats and sweets was rec-
ommended. Prenatal vitamin and mineral supple-
ments were provided for 42 of the women (48.8%), 
who were instructed to take them once a day. The 
supplements included approximately 200–300 mg 
calcium, 15 mg zinc, 17 mg iron, 400 mcg folic ac-
id, 400 IU vitamin D, 70 mg vitamin C, 3 mg thia-
mine, 2 mg riboflavin, 20 mg niacin, 6 mcg vitamin 
B12 and 10 mg vitamin E. 
The exclusion criteria for participation in the 
study were pregnancy-induced hypertension, over-
weight before pregnancy, a non-singleton preg-
nancy, gestational diabetes or the presence of any 
other complication of pregnancy. 
All the women underwent a complete clinical 
and biochemical examination. The study protocol 
also included height and weight measurement for 
body-mass index calculation (BMI = weight [kg]/ 
/height squared [m2]). Replies to a standard ques-
tionnaire were collected in person by trained inter-
viewers. Individuals were considered overweight 
when their body mass index (BMI) was > 25 kg/m2 
and < 30 kg/m2 [9]. 
Ethical Considerations
The study was planned according to the ethi-
cal standards detailed in the Declaration of Helsin-
ki (as revised in 1983) and according to local insti-
tutional guidelines. The local institutional review 
committee approved the research proposal and in-
formed consent was obtained from all the individ-
uals involved in the study. 
Analytical Methods
Venous blood was drawn from each sub-
ject’s antecubital vein after nighttime fasting 
(> 10 h) into one serum sample tube, one EDTA 
sample tube and one heparin sample tube before 
immediate centrifugation at 1500 × g for 10 min 
at 40C. Plasma and serum samples were stored at 
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–80 0C in aliquots until analysis (one month after 
the blood sampling). To measure total oxidant sta-
tus (TOS), plasma from heparinized blood samples 
was used immediately. 
Lipid status parameters (total cholesterol [T-C], 
LDL-C, HDL-C, triglyceride [TG], apolipoprotein 
A-1 [apo A-1], apolipoprotein B [apo B]), fasting 
glucose, uric acid and total protein were measured in 
serum using an Ilab 300 Plus autoanalyzer employ-
ing commercial kits (Bioanalytica, Belgrade, Serbia). 
The concentration of high sensitive C-reactive pro-
tein (hsCRP) was measured in serum by an immu-
noturbidimetric assay (Dade-Behring, BN II, Mar-
burg, Germany). The Atherogenic Index of Plasma 
(AIP) was calculated according to the following 
equation: AIP = log (TG/HDL-c), with units for 
TG and HDL-c in mmol/L [10]. The concentration 
of thiobarbituric acid-reactive substances (TBARS) 
was measured using the molar absorption coeffi-
cient of 1.56 × 105 M–1 at 535 nm, as described by 
Girotti [11]. The intra-assay and inter-assay coeffi-
cients of variance were 4.8% and 7.2% respective-
ly. Concentrations of lipid hydroperoxides (LOOH) 
were measured in serum by the ferric-xylenol orange 
method [12]. The concentration of advanced oxida-
tion protein products (AOPP) was measured as de-
scribed by Witko-Sarsat [13], employing spectro-
photometry at 340 nm. AOPP concentrations were 
expressed as chloramine-T equivalents. Total oxida-
tive status (TOS) was determined using Erel’s meth-
od [14], based on the oxidation of ferrous ion to fer-
ric ion in the presence of various oxidant species in 
serum. Ferric ion was measured using xylenol or-
ange. The assay was calibrated with hydrogen perox-
ide (H2O2) and was measured using the Ilab 300 plus 
autoanalyzer. The intra-assay and inter-assay coeffi-
cients of variance were 5.6% and 9.5% respectively. 
The results were expressed in terms of micromolar 
H2O2 equivalent per liter (umol H2O2 Equiv/L). To-
tal antioxidant capacity (TAC) was determined using 
an automated method developed by Erel [15], based 
on the de-coloration of 2.2’-azinobis-(3-ethylbenzo-
thiazoline-6-sulphonic acid radical cation (ABTS) by 
antioxidants present in serum. The color change was 
measured using the Ilab 300 Plus autoanalyzer. The 
reaction rate was calibrated with Trolox (a water-sol-
uble analogue of vitamin E, 6-hydroxy-2.5.7.8-tetra-
methylchroman-2-carboxylic acid) and sample TAC 
values were expressed as mmol Trolox equivalent/L. 
The intra-assay and inter-assay coefficients of vari-
ance were 4.3% and 8.8% respectively.
Plasma superoxide dismutase (SOD) activity 
was measured according to the method described 
by Misra and Fridovich [16]. SOD-mediated inhibi-
tion of adrenalin auto-oxidation to adrenochrome 
was monitored. One unit of SOD activity was de-
fined as the activity that inhibits the auto-oxidation 
of adrenalin by 50%. The intra-assay and inter-assay 
coefficients of variance were 6.3% and 9.2% respec-
tively. The pro-oxidant/antioxidant balance (PAB) 
was measured using a method described by Alam-
dari et al. [17], in which 3,3’,5,5’-tetramethyl benzi-
dine and its cation are used as redox indicators par-
ticipating in two simultaneous reactions. PAB values 
were expressed in arbitrary HK units, which corre-
spond to the percentage of H2O2 in the standard so-
lution. The concentration of sulfhydryl (SH) groups 
in plasma was determined using 0.2 mmol/L 5,5’- 
-dithiobis (2-nitrobenzoic acid) (DTNB) as described 
by Ellmann [18]. DTNB reacts with aliphatic thiols 
(at pH 9.0), producing 1 mole of p-nitrophenol per 
mole of thiol. p-Nitrophenol was measured by spec-
trophotometry at 412 nm. Paraoxonase-1 (PON1) 
activity was measured as the rate of diazoxone hy-
drolysis and was measured spectophotometrcal-
ly in serum using a continuous spectrophotometer 
(Pharmacia LKB, Cambridge, UK) as described by 
Richter and Furlong [19]. 
Statistical Analysis
Data are shown as mean ± standard deviation 
for normally-distributed variables and as relative or 
absolute frequencies for categorical variables. Com-
parisons of continuous variables were performed us-
ing Student’s t-test. The analyses of categorical vari-
ables used the chi-square test for contingency tables. 
A logarithmic transformation of TG levels, hsCRP 
and POase activity were performed because of the 
skewed distribution in the analysis using Student’s 
t-test [20]. Spearman’s nonparametric correlation 
analysis was employed to determine the correlations 
between the parameter of oxidative stress (TBARS) 
and lipid profile, and the oxidative stress status pa-
rameters. A multiple regression analysis was used to 
estimate the independent contribution of predictors 
to the variance in TBARS levels. Spearman’s rho cor-
relation test was used to screen the independent vari-
ables. If the P values were < 0.10, the variables were 
included in a further regression analysis. Weight gain, 
triglyceride, uric acid and hsCRP concentrations, as 
well as TAC (a representative parameter of the an-
tioxidative defense status) and TOS (representative 
of oxidative stress) were included in the primary re-
gression model. As smoking habits and vitamin in-
take could influence the TBARS concentration, those 
variables were also included in the regression model. 
The tolerance option was used to prevent multicol-
linearity among the independent variables [21]. 
All the statistical analyses were performed us-
ing Medcalc software (version 13.2). Statistical 
comparisons were considered significant at the 
0.05 probability level. 
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Results
Table 1 shows the clinical and laboratory pa-
rameters of lipid status and oxidative stress status 
parameters in pregnant women grouped according 
to their smoking habits before pregnancy. 
A significantly higher percentage of women who 
received (antioxidative) vitamin supplementation 
Table 1. Clinical and laboratory parameters, oxidative stress/antioxidative defense parameters, PON1 activities and PON1 






Age – years 29.9 ± 3.8 30.1 ± 4.6   0.862
Vitamins intake – n (%) n (36%) n (62%) < 0.05
BMI – kg/m2 26.3 ± 4.1   26.5 ± 2.8   0.869
Weight gain (%) 20.4 ± 6.6   26.5 ± 7.00 < 0.001
Week of gestation 34.4 ± 2.8   33.2 ± 1.7   0.912
SBP – mm Hg  107 ± 8.4    108 ± 7.0   0.852
DBP – mm Hg    69 ± 6.0      69 ± 7.0   0.902
Glucose – mmol/L   4.3 ± 0.5     4.4 ± 0.44   0.539
TC – mmol/L   7.0 ± 1.1     6.6 ± 1.1   0.057
LDL-C – mmol/L   3.3 ± 1.0     3.9 ± 1. < 0.05
HDL-C – mmol/L   1.9 ± 0.5     2.0 ± 0.5   0.742
TG – mmol/L# 3.01 (2.377–3.825) 2.76 (2.53–3.027) < 0.05
Apo A-I – g/L   1.6 ± 0.3     1.7 ± 0.2   0.090
Apo B – g/L 1.06 ± 0.18   1.03 ± 0.27   0.452
AIP 0.10 (–0.01–0.15) 0.18 (0.12–0.24)   0.183
Uric Acid – μmol/L 233.5 ± 45.4 247.1 ± 45.34   0.170
hsCRP – mg/L# 2.38 (1.71–3.31) 3.01 (2.38–3.82)   0.240
TBARS – μmol/L     1.7 ± 0.8     2.3 ± 1.0 < 0.05
LOOH – μmol/L     9.3 ± 2.7     3.4 ± 2.3   0.846
AOPP – μmol/L   21.6 ± 7.45   21.6 ± 7.0   0.971
PAB – HK units 159.4 ± 34.6 167.7 ± 29.2   0.250
TOS – μmol/L   15.9 ± 5.4   18.9 ± 5.4 < 0.05
TAC – mmol/L   1.28 ± 0.15   1.30 ± 0.18   0.571
SOD – kU/L 158.0 ± 11.16 150.3 ± 34.0   0.362
SH-groups – g/L   0.49 ± 0.06   0.48 ± 0.08   0.849
POase – U/L# 342.7 (231.5–507.3) 253.01 (201.0–318.5) < 0.05
DZOase – U/L  5219 ± 2944 5107 ± 3577   0.877
PON1 phenotype (%)    
QQ  4.5%  3%   0.062
QR 34% 17%  
RR 61.5% 80%  
Data are expressed as mean ± SD; # – means and 95th confidence intervals derived from log-normal values.
1 Continuous variables were compared using Student’s t-test and categorical variables by the c2 test. 
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was present in the smokers’ group (Table 1). Also, 
weight gain was significantly higher in that group 
compared with the non-smokers (p < 0.001). LDL-c 
concentrations were significantly higher and trig-
lyceride concentrations significantly lower in the 
smokers’ group. No other significant differences in 
lipid profile parameters were present between the 
two groups, but those parameter concentrations 
were close to high risk levels.
In this study only non-complicated pregnan-
cies were investigated, so it is not surprising that 
no significant differences in glucose levels, uric ac-
id levels and hsCRP concentrations were found be-
tween the two groups. 
TBARS and TOS concentrations were significant-
ly higher in the smokers’ group, while PON1 activity 
was significantly lower (Table 1). The other oxidative 
stress status parameters were similar in both groups. 
Table 2. Clinical and laboratory parameters, oxidative stress/antioxidative defense parameters, PON1 activities and PON1 
phenotype distribution in the two study groups according to maternal vitamin supplementation during pregnancy





Age – years   30.1 ± 3.2   29.8 ± 4.1   0.906
Smoking – n (%) n (36%) n (62%) < 0.05
BMI – kg/m2   26.6 ± 3.6   26.3 ± 3.4   0.711
Weight gain (%)   23.2 ± 6.4   23.6 ± 8.4   0.803
Week of gestation   34.4 ± 2.9   34.5 ± 2.9   0.891
SBP – mm Hg    107 ± 10.1    108 ± 8.3   0.762
DBP – mm Hg      69 ± 7.1      68 ± 6.9   0.915
Glucose – mmol/L     4.4 ± 0.6     4.3 ± 0.4   0.727
TC – mmol/L     6.7 ± 1.0     6.9 ± 1.1   0.447
LDL-C – mmol/L     3.6 ± 1.0     3.7 ± 1.1   0.958
HDL-C – mmol/L     1.9 ± 0.4     2.0 ± 0.5   0.690
TG – mmol/L# 2.4 (2.18–2.65) 2.7 (2.49–2.94)   0.112
Apo A-I – g/L     1.6 ± 0.3     1.7 ± 0.3   0.788
Apo B – g/L   1.04 ± 0.18   1.07 ± 0.17   0.443
AIP 0.11 (0.021–0.140) 0.17 (0.100–0.218)   0.284
Uric Acid – μmol/L 235.9 ± 17.6 244.9 ± 13.4   0.368
hsCRP – mg/L# 2.9 (2.26–3.75) 2.5 (1.79–3.39)   0.790
TBARS – μmol/L     1.9 ± 0.3     1.9 ± 0.1   0.979
LOOH – μmol/L     9.1 ± 2.6     9.5 ± 2.3   0.343
AOPP – μmol/L   22.4 ± 7.5   20.7 ± 6.8   0.270
PAB – HK units 163.5 ± 31.8 163.4 ± 32.9   0.970
TOS – μmol/L   16.9 ± 5.9   17.6 ± 5.2   0.591
TAC – mmol/L   1.31 ± 0.16   1.28 ± 0.16   0.497
SOD – kU/L 147.9 ± 17.8 160.8 ± 17.9   0.128
SH-groups – g/L   0.49 ± 0.07   0.48 ± 0.08   0.529
POase – U/L# 257.0 (198.4–332.9) 334.0 (231.5–484.2)   0.239
DZOase – U/L 5145 ± 3040  5186 ± 3479   0.955
Data are expressed as mean ± SD; # – means and 95th confidence intervals derived from log-normal values.
1 Continuous variables were compared using Student’s t-test and categorical variables by the c2 test. 
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Table 2 shows the same parameters for wom-
en with or without (antioxidative) vitamin supple-
mentation. No significant differences were found 
in any parameter between the two vitamin-supple-
mentation groups (Table 2). 
Spearman’s correlation analyses were per-
formed to test for associations between oxidative 
stress parameters and other parameters. (Table 3). 
TBARS was significantly positively correlated with 
BMI, weight gain, triglyceride, TOS, PAB concen-
trations and SOD activity, and significantly nega-
tively correlated with TAC (Table 3).
Table 4 summarizes the multiple regression 
analysis to examine the influence of weight gain, 
smoking, TG, vitamin intake, uric acid, hsCRP, 
TAC and TOS as independent variables on TBARS. 
Weight gain, TAC and TOS concentrations were 
independently associated with the concentration 
of TBARS. Unexpectedly, habitual maternal smok-
ing before pregnancy was not independently asso-
ciated with the concentration of TBARS. 
To prevent multicolinearity, TAC and TOS 
concentrations as parameters of oxidative stress 
status were excluded from Model 2 (Table 5). This 
showed that weight gain was independently associ-
ated with the concentration of TBARS. 
Discussion 
Pregnancy is a physiological condition with 
changed lipid profile parameters [1] and increased 
susceptibility to oxidative stress [2]. During preg-
nancy, increased production of ROS exceeding 
the mother’s antioxidant potential leads to oxida-
tive stress, which can negatively affect the health of 
both the mother and the fetus, leading to compli-
cations in pregnancy, as well as adverse pregnan-
cy outcomes [2]. It is well known that smoking is 
followed by intense oxidative stress [3]. Pregnancy 
Table 3. Spearman’s non-parametric correlations between 
TBARS and biochemical and oxidative status parameters
Parameter ρ p
BMI  0.710 < 0.001
Weight gain (%)  0.846 < 0.001
Glucose – mmol/L  0.146   0.278
T-C – mmol/L  0.082   0.546
LDL-C – mmol/L  0.125   0.353
HDL-C – mmol/L  0.058   0.671
TG – mmol/L#  0.415 < 0.001
Apo A1 – g/L  0.204   0.127
Apo B – g/L  0.171   0.205
AIP  0.206   0.125
Uric acid – μmol/L  0.257   0.056
hsCRP – mg/L  0.238   0.075
LOOH – μmol/L –0.056   0.678
AOPP – μmol/L  0.120   0.375
PAB – HK units  0.417 < 0.001
TOS – μmol/L  0.739 < 0.001
TAC – mmol/L –0.468 < 0.001
SOD – kU/L  0.314 < 0.05
SH-groups – g/L –0.122   0.365
POase activity – U/L –0.125   0.428
DZOase activity  0.171   0.212
Table 4. Multiple regression analysis for the association of 





adjusted R2 = 0.813
β SE (β) P
Weight gain (%)  0.525 0.011 < 0.001
Smoking  0.110 0.124  0.116
Vitamin supplementation –0.064 0.112  0.306
TG – mmol/L  0.014 0.087  0.848
Uric acid – μmol/L –0.131 0.002  0.145
hsCRP – mg/L  0.081 0.015  0.195
TOS – μmol/L  0.367 0.016 < 0.001
TAC – mmol/L –0.342 0.715 < 0.001
Table 5. Multiple regression analysis for the association of 





adjusted R2 = 0.762
β SE (β) P
Weight gain (%)  0.847 0.009 < 0.001
Smoking  0.084 0.145   0.280
Vitamin supplementation –0.059 0.129   0.394
TG – mmol/L  0.124 0.086   0.086
Uric acid – μmol/L  0.010 0.001   0.880
hsCRP – mg/L  0.122 0.017   0.073
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complications can arise due to the increased free 
radical damage caused by smoking [4]. Cigarette 
smoking leads to increases in the concentrations 
of serum TC, LDL-c and TG, and decreases in the 
level of anti-atherogenic HDL-c [22]. It is pre-
sumed that, as Jeeyar et al. wrote, “nicotine stim-
ulates the sympathetic adrenal system leading to 
increased secretion of catecholamines resulting in 
increased lipolysis and increased concentration of 
plasma-free fatty acids, which results in increased 
synthesis of hepatic TG, along with VLDL-c in the 
blood stream” [22]. 
High levels of LDL-c, VLDL-c, and TG are 
strongly associated with the development of coro-
nary artery disease [22]. 
Tobacco smoke contains a large number of 
free radicals that are capable of initiating or pro-
moting oxidative injury [5]. Smokers have higher 
concentrations of oxidatively modified lipid prod-
ucts than non-smokers [22]. The current study 
showed that pregnant women who smoked had 
significantly higher LDL-c (p < 0.05) than preg-
nant non-smokers (Table 1). LDL-c from smok-
ers was more susceptible to peroxidative modifica-
tion when compared with that from non-smokers 
[23], and oxidation of LDL-c might be an impor-
tant mechanism whereby cigarette smoking can 
accelerate atherogenesis [22].
PON1 (aryldialkylphosphatase, EC 3.1.8.1) is 
an esterase binding to HDL that metabolizes oxi-
dative LDL-c particles and has strong antioxidant 
potential [8]. Min et al. reported that low levels of 
PON1 in preeclamptic women lead to lipid per-
oxidation and increased susceptibility to the ox-
idation of LDL-cholesterol [24]. Low PON1 ac-
tivities could be associated with an increased risk 
of developing CVD [24]. Significant reduction in 
PON1 activity during uncomplicated pregnan-
cies has been described by Ferre et al. [25]. In the 
present study, pregnant women who smoked had 
significantly lower PON1 activity (p < 0.05) than 
pregnant non-smokers. Although PON1 activity 
differed significantly between smokers and non-
smokers, no difference was found in the distribu-
tion of PON1 phenotypes between those groups. 
The PON1 polymorphism phenotype appears to 
be involved in the pathogenesis of some diseases, 
especially CVD and diabetes mellitus type 2 [8].
Pregnancy has been described in numerous 
studies [1, 2, 6] as a physiological state with a pro-
atherogenic effect, an altered lipid profile and in-
creased oxidative stress. The results of the present 
study show that pregnant smokers are at a great-
er risk of developing atherosclerosis than pregnant 
non-smokers, as they have significantly higher lev-
els of LDL-c and TBARS, as well as lower PON1 
enzyme activity. Pregnant women who smoked 
before pregnancy had higher TOS values (p < 0.05) 
compared with women who were non-smok-
ers (Table 1). Also, their concentration of TBARS 
was significantly higher, while PON1 activity was 
significantly lower compared with non-smokers. 
These results indicate that pregnant smokers are in 
a state of increased oxidative stress. This is com-
patible with the findings of Aycicek et al. [26], who 
reported that TOS was significantly higher in the 
active and passive smoker groups than in the non-
smoking controls. TBARS includes MDA and re-
lated aldehydes, which are by-products of lipid 
peroxidation and which are responsible for some 
of the damaging effects of free radicals on DNA 
and on cell membranes [27]. According to Devasa-
gayam et al., the damage to some cellular structures 
caused by lipid peroxidation “is highly detrimental 
to the functioning of the cell and its survival” [27].
Higher concentrations of hydroperoxides have 
been found in pregnant smokers than in non-smok-
ers [5]. Chelchovska et al. also found a positive cor-
relation between MDA and cotinine concentrations 
(the major metabolite of nicotine in body fluids), both 
in smoking mothers and in their children [5]. 
Regarding the effects of smoking on antioxida-
tive markers, a linear relationship has been found 
between smoking duration, daily cigarette con-
sumption, lipid peroxidation, and nitric oxide for-
mation both in plasma and erythrocytes [28]. In 
that study, when smokers stopped smoking for six 
months, plasma levels of vitamin C and E, beta-
carotene, erythrocyte superoxide dismutase, cata-
lase and glutathione peroxidase were higher than 
in those who continued to smoke, but remained 
significantly lower than those of a matched non-
smoking group [28]. 
As a further step, the authors of the current 
study wanted to establish whether smoking was 
the primary reason for increased concentrations of 
TBARS, the main indicator of oxidative stress. For 
this purpose, multiple regression analysis was used 
as a test model in which smoking and other pa-
rameters that showed a significant correlation with 
TBARS were included. The results unexpectedly 
showed that weight gain during pregnancy, but not 
smoking, was an independent positive predictor of 
an increased concentration of TBARS (Table 5).
Among the participants in the current study, 
pregnant smokers had a significantly higher weight 
gain during pregnancy (p < 0.001) than non-smok-
ers (Table 1). Since cigarette smoking decreases ap-
petite [29], it seems likely that the gains in weight 
were a consequence of stopping cigarette smoking 
during pregnancy. 
Weight gain during pregnancy is also associ-
ated with altered lipid parameters that have a pro-
atherogenic character [30]. Although smoking and 
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diabetes have been associated with increased ox-
idative stress in a number of studies, the finding 
that obesity, as measured by BMI, is independent-
ly associated with oxidative stress is relatively new 
[30]. In view of the results of the present study it 
can be said that pregnant smokers who have a sig-
nificantly higher weight gain than pregnant non-
smokers undergo greater oxidative stress. Although 
all the pregnant women who smoked in the pres-
ent study finished their pregnancies without com-
plications, the results suggest that weight gain is an 
independent risk factor for the development of ox-
idative stress. However, the pregnant women who 
had smoked before pregnancy had higher TACs 
than pregnant non-smokers, suggesting that these 
women preserved their antioxidant potential, and 
this may explain why they brought their pregnan-
cies to term without complications.
Pregnant women who took vitamin supple-
ments showed no significant differences in the lev-
els  of antioxidant defense parameters in compar-
ison with women who did not use supplements 
(Table 2). This may be explained by the fact that all 
the pregnant women were advised to include a lot 
of fruits and vegetables in their diets and thus they 
could have had a sufficient intake of antioxidants. 
In the present study there was a significantly 
higher percent of smokers in the group of wom-
en who received antioxidative supplementation 
(62%). Cigarette smoke decreases antioxidant po-
tential, which may explain the lack of any demon-
strable effect of supplementation on the parame-
ters of antioxidant defense. All the women were 
healthy with an intact antioxidant potential that 
was not compromised by any complications of 
pregnancy.
Studies have shown lower α-tocopherol retin-
ol, and β-carotene levels in maternal plasma and 
cord plasma in smokers [5], though another study 
showed no differences between smokers and non-
smokers in antioxidant vitamin levels in maternal 
plasma and cord plasma [3].
Some authors have shown that taking vita-
mins, especially vitamin C and vitamin E, may 
have a positive effect on pregnancy and birth out-
come [6]. On the other hand, a healthy diet rich in 
fruits and vegetables can also provide enough vita-
mins and minerals [7] for a normal pregnancy.
The present study confirmed that smoking 
habits before pregnancy were associated with in-
creased oxidative stress, lipid changes expressed 
through the creation of increased LDL-c, and de-
creased PON1 activity. A multiple regression anal-
ysis showed that weight gain during pregnancy, 
not smoking, increases TBARS. In addition, the 
results indicate that vitamin supplementation has 
no effect on the parameters of oxidative stress sta-
tus in healthy pregnant women. 
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